Dale J. Lange

8.5k total citations
85 papers, 3.4k citations indexed

About

Dale J. Lange is a scholar working on Neurology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Dale J. Lange has authored 85 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Neurology, 22 papers in Genetics and 22 papers in Cellular and Molecular Neuroscience. Recurrent topics in Dale J. Lange's work include Amyotrophic Lateral Sclerosis Research (39 papers), Peripheral Neuropathies and Disorders (23 papers) and Neurogenetic and Muscular Disorders Research (21 papers). Dale J. Lange is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (39 papers), Peripheral Neuropathies and Disorders (23 papers) and Neurogenetic and Muscular Disorders Research (21 papers). Dale J. Lange collaborates with scholars based in United States, Sweden and Canada. Dale J. Lange's co-authors include Robert E. Lovelace, Lewis P. Rowland, Arthur P. Hays, W. Trojaborg, Stanley Fahn, Mitchell F. Brin, Thomas H. Brannagan, Antonino Uncini, Giulio Maria Pasinetti and Lap Ho and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Neurology.

In The Last Decade

Dale J. Lange

82 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dale J. Lange United States 31 2.3k 780 633 563 500 85 3.4k
Jonathan Katz United States 29 1.9k 0.8× 754 1.0× 534 0.8× 600 1.1× 448 0.9× 78 3.0k
Wilson W. Bryan United States 32 2.4k 1.1× 798 1.0× 246 0.4× 788 1.4× 763 1.5× 46 4.1k
Tomio Sasaki Japan 37 1.9k 0.8× 728 0.9× 567 0.9× 489 0.9× 1.1k 2.2× 155 4.4k
Khema R. Sharma United States 27 1.1k 0.5× 565 0.7× 323 0.5× 486 0.9× 805 1.6× 51 2.6k
Kazuaki Kanai Japan 33 2.2k 1.0× 1.4k 1.7× 414 0.7× 654 1.2× 698 1.4× 103 3.1k
Juan M. Bilbao Canada 33 1.6k 0.7× 383 0.5× 366 0.6× 797 1.4× 805 1.6× 91 3.4k
Yuishin Izumi Japan 31 1.7k 0.8× 871 1.1× 491 0.8× 476 0.8× 805 1.6× 218 3.2k
Gérard Saïd France 31 1.5k 0.7× 812 1.0× 1.2k 1.9× 253 0.4× 1.5k 3.0× 84 4.2k
Nicolette C. Notermans Netherlands 30 1.8k 0.8× 1.4k 1.8× 579 0.9× 195 0.3× 586 1.2× 114 2.9k
Laurent Magy France 31 2.0k 0.9× 1.4k 1.8× 479 0.8× 358 0.6× 587 1.2× 165 3.8k

Countries citing papers authored by Dale J. Lange

Since Specialization
Citations

This map shows the geographic impact of Dale J. Lange's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dale J. Lange with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dale J. Lange more than expected).

Fields of papers citing papers by Dale J. Lange

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dale J. Lange. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dale J. Lange. The network helps show where Dale J. Lange may publish in the future.

Co-authorship network of co-authors of Dale J. Lange

This figure shows the co-authorship network connecting the top 25 collaborators of Dale J. Lange. A scholar is included among the top collaborators of Dale J. Lange based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dale J. Lange. Dale J. Lange is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perrin, Steven, Shafeeq Ladha, Nicholas J. Maragakis, et al.. (2024). Safety and tolerability of tegoprubart in patients with amyotrophic lateral sclerosis: A Phase 2A clinical trial. PLoS Medicine. 21(10). e1004469–e1004469. 2 indexed citations
2.
Weidman, Elizabeth K., Andrew D. Schweitzer, Sumit N. Niogi, et al.. (2018). Diffusion tensor imaging and quantitative susceptibility mapping as diagnostic tools for motor neuron disorders. Clinical Imaging. 53. 6–11. 15 indexed citations
3.
Lange, Dale J., et al.. (2016). Role of Neuronavigation for Training and Improvement of Accuracy During Transcranial Magnetic Stimulation (P6.262). Neurology. 86(16_supplement). 1 indexed citations
4.
Schweitzer, Andrew D., Tian Liu, Yi Wang, et al.. (2015). Quantitative Susceptibility Mapping (QSM) as a biomarker for C9orf72 Familial ALS (P6.027). Neurology. 84(14_supplement). 1 indexed citations
5.
Lange, Dale J., et al.. (2013). Pain in Multifocal Motor Neuropathy (P01.146). Neurology. 80(7_supplement). 1 indexed citations
6.
Lange, Dale J., et al.. (2013). Can white matter changes occur in disorders of peripheral nerve hyperexcitability?. Multiple Sclerosis and Related Disorders. 2(4). 388–390. 1 indexed citations
7.
Zhao, Wei, Merina Varghese, Prashant Vempati, et al.. (2012). Caprylic Triglyceride as a Novel Therapeutic Approach to Effectively Improve the Performance and Attenuate the Symptoms Due to the Motor Neuron Loss in ALS Disease. PLoS ONE. 7(11). e49191–e49191. 103 indexed citations
8.
Lange, Dale J., et al.. (2011). Do A‐waves help predict intravenous immunoglobulin response in multifocal motor neuropathy without block?. Muscle & Nerve. 43(4). 537–542. 2 indexed citations
9.
Zhao, Zhong, Dale J. Lange, Lap Ho, et al.. (2008). Vgf is a novel biomarker associated with muscle weakness in amyotrophic lateral sclerosis (ALS), with a potential role in disease pathogenesis. International Journal of Medical Sciences. 5(2). 92–99. 51 indexed citations
10.
Handkiewicz-Junak, Daria, Józef Roskosz, Jan Włoch, et al.. (2001). Prognostic factors for differentiated thyroid carcinoma in young patients. Nowotwory Journal of Oncology. 51(4). 365–365. 3 indexed citations
11.
Czarniecka, Agnieszka, Jan Włoch, & Dale J. Lange. (2001). [Clinical picture of differentiated thyroid carcinoma in the T1 stage].. PubMed. 54 Suppl 1. 225–33. 3 indexed citations
12.
Chan, Stephen, et al.. (1999). Motor Neuron Diseases: Comparison of Single-Voxel Proton MR Spectroscopy of the Motor Cortex with MR Imaging of the Brain. Radiology. 212(3). 763–769. 86 indexed citations
13.
Shimada, Atsuyoshi, Dale J. Lange, & Arthur P. Hays. (1999). Amyotrophic lateral sclerosis in an adult following acute paralytic poliomyelitis in early childhood. Acta Neuropathologica. 97(3). 317–321. 7 indexed citations
14.
Brannagan, Thomas H., Keith J. Nagle, Dale J. Lange, & Lewis P. Rowland. (1996). Complications of intravenous immune globulin treatment in neurologic disease. Neurology. 47(3). 674–677. 162 indexed citations
15.
Lange, Dale J.. (1995). Post‐Polio Muscular Atrophy. Annals of the New York Academy of Sciences. 753(1). 151–157. 6 indexed citations
16.
Lange, Dale J.. (1994). AAEM minimonograph #41: Neuromuscular diseases associated with HIV‐1 infection. Muscle & Nerve. 17(1). 16–30. 27 indexed citations
17.
Lange, Dale J., et al.. (1993). Persistent and transient “conduction block” in motor neuron diseases. Muscle & Nerve. 16(9). 896–903. 27 indexed citations
18.
Cafferty, Maureen, et al.. (1989). Neuromuscular involvement in mild, asymptomatic primary hyperparathyroidism. The American Journal of Medicine. 87(5). 553–557. 65 indexed citations
19.
Uncini, Antonino, et al.. (1989). Ring finger testing in carpal tunnel syndrome: A comparative study of diagnostic utility. Muscle & Nerve. 12(9). 735–741. 109 indexed citations
20.
Brin, Mitchell F., Stanley Fahn, Carol Moskowitz, et al.. (1987). Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm. Movement Disorders. 2(4). 237–254. 321 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jonathan Katz Breakdown of academic impact, for papers by Wilson W. Bryan Breakdown of academic impact, for papers by Tomio Sasaki Breakdown of academic impact, for papers by Khema R. Sharma Breakdown of academic impact, for papers by Kazuaki Kanai Breakdown of academic impact, for papers by Juan M. Bilbao Breakdown of academic impact, for papers by Yuishin Izumi Breakdown of academic impact, for papers by Gérard Saïd Breakdown of academic impact, for papers by Nicolette C. Notermans Breakdown of academic impact, for papers by Laurent Magy
Rankless by CCL
2026